CD44 and cancer: As a highly specific osteolysis biomarker, SPP1 and type I collagen have been previously shown to be expressed and secreted by a variety of cancers, and participate in cell adhesion, bone resorption, cell adhesion, metastasis and other processes by binding to CD44 and integrin receptors (54–58).